ACA
KRYS icon

Avoro Capital Advisors’s Krystal Biotech KRYS Stock Holding History

Avoro Capital Advisors’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$746M Hold
2,888,888
– – 7.34% 4
2025
Q4 		$712M Buy
2,888,888
+111,111
+4% +$23.4M 7% 5
2025
Q3 		$490M Buy
2,777,777
+117,777
+4% +$17.6M 6.34% 5
2025
Q2 		$366M Sell
2,660,000
-71,000
-3% -$10.4M 6.4% 5
2025
Q1 		$492M Buy
2,731,000
+102,178
+4% +$17.2M 7.69% 5
2024
Q4 		$412M Buy
2,628,822
+6,600
+0.3% +$1.17M 5.83% 5
2024
Q3 		$477M Buy
2,622,222
+189,222
+8% +$36.5M 6.96% 4
2024
Q2 		$447M Sell
2,433,000
-122,555
-5% -$20.6M 5.95% 6
2024
Q1 		$455M Sell
2,555,555
-10,000
-0.4% -$1.39M 5.3% 7
2023
Q4 		$318M Hold
2,565,555
– – 4.4% 11
2023
Q3 		$298M Buy
2,565,555
+4,744
+0.2% +$579K 4.64% 10
2023
Q2 		$301M Buy
2,560,811
+810,811
+46% +$82.8M 4.08% 12
2023
Q1 		$140M Buy
1,750,000
+340,000
+24% +$26.7M 2.08% 15
2022
Q4 		$112M Buy
1,410,000
+135,000
+11% +$10M 1.67% 15
2022
Q3 		$88.9M Buy
1,275,000
+200,000
+19% +$14.4M 1.64% 16
2022
Q2 		$70.6M Buy
1,075,000
+70,000
+7% +$4.35M 1.39% 16
2022
Q1 		$66.9M Buy
1,005,000
+530,000
+112% +$33.1M 1.22% 18
2021
Q4 		$33.2M Buy
+475,000
New +$27.6M 0.57% 30

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $9.98B AUM 145.42% 1-Year Est. Return

Avoro Capital Advisors's KRYS Position: Q1 2026 in Review

Avoro Capital Advisors held its Krystal Biotech (KRYS) position steady in Q1 2026 at 2,888,888 shares worth $746M. The position accounts for 7.34% of the portfolio, ranked #4.

Avoro Capital Advisors first reported a position in KRYS in Q4 2021 and has held it in 18 quarters since. 367 funds tracked by Wall St. Rank hold KRYS as of Q1 2026.

  • Avoro Capital Advisors held 2,888,888 shares of Krystal Biotech worth $746M as of Q1 2026.
  • Avoro Capital Advisors left its Krystal Biotech share count unchanged in Q1 2026.
  • Krystal Biotech made up 7.34% of Avoro Capital Advisors's portfolio in Q1 2026, its #4 holding.
  • Avoro Capital Advisors first reported a position in Krystal Biotech in Q4 2021 and has held it in 18 quarters since.
  • 367 funds tracked by Wall St. Rank held Krystal Biotech as of Q1 2026.

Based on Avoro Capital Advisors's 13F filing for Q1 2026, filed 15 May 2026.